11-46702739-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_024741.3(ZNF408):c.366C>G(p.Ala122Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0164 in 1,614,084 control chromosomes in the GnomAD database, including 3,814 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.086 ( 1902 hom., cov: 33)
Exomes 𝑓: 0.0091 ( 1912 hom. )
Consequence
ZNF408
NM_024741.3 synonymous
NM_024741.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.890
Publications
3 publications found
Genes affected
ZNF408 (HGNC:20041): (zinc finger protein 408) The protein encoded by this gene contains ten tandem zinc fingers and an N-terminal SET domain, so it is likely a DNA binding protein that interacts with other proteins. In adults, the encoded protein is expressed most highly in retina. Consequently, defects in this gene have been associated with familial exudative vitreoretinopathy (FEVR) and retinitis pigmentosa (RP). [provided by RefSeq, Dec 2016]
ZNF408 Gene-Disease associations (from GenCC):
- exudative vitreoretinopathy 6Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- retinitis pigmentosa 72Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- exudative vitreoretinopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 11-46702739-C-G is Benign according to our data. Variant chr11-46702739-C-G is described in ClinVar as Benign. ClinVar VariationId is 261759.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.89 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ZNF408 | ENST00000311764.3 | c.366C>G | p.Ala122Ala | synonymous_variant | Exon 3 of 5 | 1 | NM_024741.3 | ENSP00000309606.2 | ||
| ZNF408 | ENST00000526410.1 | n.383C>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 3 | |||||
| ZNF408 | ENST00000527008.1 | n.25C>G | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
| ZNF408 | ENST00000534481.1 | n.505C>G | non_coding_transcript_exon_variant | Exon 2 of 2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0862 AC: 13111AN: 152126Hom.: 1893 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
13111
AN:
152126
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0222 AC: 5588AN: 251482 AF XY: 0.0165 show subpopulations
GnomAD2 exomes
AF:
AC:
5588
AN:
251482
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00915 AC: 13373AN: 1461840Hom.: 1912 Cov.: 31 AF XY: 0.00786 AC XY: 5719AN XY: 727212 show subpopulations
GnomAD4 exome
AF:
AC:
13373
AN:
1461840
Hom.:
Cov.:
31
AF XY:
AC XY:
5719
AN XY:
727212
show subpopulations
African (AFR)
AF:
AC:
10816
AN:
33454
American (AMR)
AF:
AC:
676
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
26
AN:
26136
East Asian (EAS)
AF:
AC:
1
AN:
39700
South Asian (SAS)
AF:
AC:
92
AN:
86256
European-Finnish (FIN)
AF:
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
AC:
91
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
448
AN:
1112000
Other (OTH)
AF:
AC:
1223
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
520
1040
1559
2079
2599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
312
624
936
1248
1560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0863 AC: 13145AN: 152244Hom.: 1902 Cov.: 33 AF XY: 0.0839 AC XY: 6244AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
13145
AN:
152244
Hom.:
Cov.:
33
AF XY:
AC XY:
6244
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
12468
AN:
41492
American (AMR)
AF:
AC:
454
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
10
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
AC:
56
AN:
68038
Other (OTH)
AF:
AC:
139
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
480
960
1441
1921
2401
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
74
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:2
May 09, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.